AEHR TEST SYSTEMS — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that AEHR TEST SYSTEMS filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 30, 2025 | $58.97M | Jul 28, 2025 |
| FY2025 | May 31, 2024 | $66.22M | Jul 28, 2025 |
| FY2025 | May 31, 2023 | $64.96M | Jul 28, 2025 |
| FY2022 | May 31, 2022 | $20.29M | Aug 26, 2022 |
| FY2022 | Feb 28, 2022 | $15.28M | Aug 26, 2022 |
| FY2022 | Nov 30, 2021 | $9.61M | Aug 26, 2022 |
| FY2022 | Aug 31, 2021 | $5.65M | Aug 26, 2022 |
| FY2022 | May 31, 2021 | $7.64M | Aug 26, 2022 |
| FY2022 | Feb 28, 2021 | $5.27M | Aug 26, 2022 |
| FY2022 | Nov 30, 2020 | $1.68M | Aug 26, 2022 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 30, 2025 | $58.97M | Jul 28, 2025 |
| FY2025 | May 31, 2024 | $66.22M | Jul 28, 2025 |
| FY2025 | May 31, 2023 | $64.96M | Jul 28, 2025 |
| FY2024 | May 31, 2022 | $50.83M | Jul 30, 2024 |
| FY2023 | May 31, 2021 | $16.60M | Aug 28, 2023 |
| FY2022 | May 31, 2020 | $22.29M | Aug 26, 2022 |
| FY2021 | May 31, 2019 | $21.06M | Aug 27, 2021 |
| FY2020 | May 31, 2018 | $29.56M | Aug 28, 2020 |
| FY2019 | May 31, 2017 | $18.90M | Aug 28, 2019 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 30, 2025 | $23.93M | Jul 28, 2025 |
| FY2025 | May 31, 2024 | $32.54M | Jul 28, 2025 |
| FY2025 | May 31, 2023 | $32.75M | Jul 28, 2025 |
| FY2022 | May 31, 2022 | $10.47M | Aug 26, 2022 |
| FY2022 | Feb 28, 2022 | $6.40M | Aug 26, 2022 |
| FY2022 | Nov 30, 2021 | $4.52M | Aug 26, 2022 |
| FY2022 | Aug 31, 2021 | $2.28M | Aug 26, 2022 |
| FY2022 | May 31, 2021 | $3.53M | Aug 26, 2022 |
| FY2022 | Feb 28, 2021 | $1.89M | Aug 26, 2022 |
| FY2022 | Nov 30, 2020 | $377.0K | Aug 26, 2022 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 30, 2025 | ($3.91M) | Jul 28, 2025 |
| FY2025 | May 31, 2024 | $33.16M | Jul 28, 2025 |
| FY2025 | May 31, 2023 | $14.56M | Jul 28, 2025 |
| FY2022 | May 31, 2022 | $5.79M | Aug 26, 2022 |
| FY2022 | Feb 28, 2022 | $2.24M | Aug 26, 2022 |
| FY2022 | Nov 30, 2021 | $717.0K | Aug 26, 2022 |
| FY2022 | Aug 31, 2021 | $696.0K | Aug 26, 2022 |
| FY2022 | May 31, 2021 | $567.0K | Aug 26, 2022 |
| FY2022 | Feb 28, 2021 | ($735.0K) | Aug 26, 2022 |
| FY2022 | Nov 30, 2020 | ($1.97M) | Aug 26, 2022 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 30, 2025 | ($5.68M) | Jul 28, 2025 |
| FY2025 | May 31, 2024 | $10.08M | Jul 28, 2025 |
| FY2025 | May 31, 2023 | $13.38M | Jul 28, 2025 |
| FY2024 | May 31, 2022 | $7.80M | Jul 30, 2024 |
| FY2023 | May 31, 2021 | ($4.18M) | Aug 28, 2023 |
| FY2022 | May 31, 2020 | ($2.77M) | Aug 26, 2022 |
| FY2021 | May 31, 2019 | ($5.00M) | Aug 27, 2021 |
| FY2020 | May 31, 2018 | $915.0K | Aug 28, 2020 |
| FY2019 | May 31, 2017 | ($4.93M) | Aug 28, 2019 |
| FY2018 | May 31, 2016 | ($6.15M) | Aug 28, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 30, 2025 | $10.46M | Jul 28, 2025 |
| FY2025 | May 31, 2024 | $8.72M | Jul 28, 2025 |
| FY2025 | May 31, 2023 | $7.13M | Jul 28, 2025 |
| FY2024 | May 31, 2022 | $5.82M | Jul 30, 2024 |
| FY2023 | May 31, 2021 | $3.65M | Aug 28, 2023 |
| FY2022 | May 31, 2020 | $3.39M | Aug 26, 2022 |
| FY2021 | May 31, 2019 | $4.15M | Aug 27, 2021 |
| FY2020 | May 31, 2018 | $4.18M | Aug 28, 2020 |
| FY2019 | May 31, 2017 | $4.66M | Aug 28, 2019 |
| FY2018 | May 31, 2016 | $4.32M | Aug 28, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 30, 2025 | $18.28M | Jul 28, 2025 |
| FY2025 | May 31, 2024 | $13.75M | Jul 28, 2025 |
| FY2025 | May 31, 2023 | $12.24M | Jul 28, 2025 |
| FY2024 | May 31, 2022 | $10.05M | Jul 30, 2024 |
| FY2023 | May 31, 2021 | $6.56M | Aug 28, 2023 |
| FY2022 | May 31, 2020 | $7.53M | Aug 26, 2022 |
| FY2021 | May 31, 2019 | $7.72M | Aug 27, 2021 |
| FY2020 | May 31, 2018 | $7.29M | Aug 28, 2020 |
| FY2019 | May 31, 2017 | $7.05M | Aug 28, 2019 |
| FY2018 | May 31, 2016 | $6.98M | Aug 28, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 30, 2025 | ($7.40M) | Jul 28, 2025 |
| FY2025 | May 31, 2024 | $1.76M | Jul 28, 2025 |
| FY2025 | May 31, 2023 | $10.01M | Jul 28, 2025 |
| FY2024 | May 31, 2022 | $1.51M | Jul 30, 2024 |
| FY2023 | May 31, 2021 | ($2.70M) | Aug 28, 2023 |
| FY2022 | May 31, 2020 | ($2.02M) | Aug 26, 2022 |
| FY2021 | May 31, 2019 | ($5.64M) | Aug 27, 2021 |
| FY2020 | May 31, 2018 | ($1.35M) | Aug 28, 2020 |
| FY2019 | May 31, 2017 | ($4.50M) | Aug 28, 2019 |
| FY2018 | May 31, 2016 | ($6.28M) | Aug 28, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 30, 2025 | $4.99M | Jul 28, 2025 |
| FY2025 | May 31, 2024 | $749.0K | Jul 28, 2025 |
| FY2025 | May 31, 2023 | $1.36M | Jul 28, 2025 |
| FY2024 | May 31, 2022 | $416.0K | Jul 30, 2024 |
| FY2023 | May 31, 2021 | $227.0K | Aug 28, 2023 |
| FY2022 | May 31, 2020 | $163.0K | Aug 26, 2022 |
| FY2021 | May 31, 2019 | $173.0K | Aug 27, 2021 |
| FY2020 | May 31, 2018 | $572.0K | Aug 28, 2020 |
| FY2019 | May 31, 2017 | $477.0K | Aug 28, 2019 |
| FY2018 | May 31, 2016 | $919.0K | Aug 28, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 30, 2025 | $148.51M | Jul 28, 2025 |
| FY2025 | May 31, 2024 | $127.91M | Jul 28, 2025 |
| FY2024 | May 31, 2023 | $98.14M | Jul 30, 2024 |
| FY2023 | May 31, 2022 | $62.33M | Aug 28, 2023 |
| FY2022 | May 31, 2021 | $21.67M | Aug 26, 2022 |
| FY2021 | May 31, 2020 | $20.57M | Aug 27, 2021 |
| FY2020 | May 31, 2019 | $21.31M | Aug 28, 2020 |
| FY2019 | May 31, 2018 | $30.96M | Aug 28, 2019 |
| FY2018 | May 31, 2017 | $30.89M | Aug 28, 2018 |
| FY2017 | May 31, 2016 | $10.05M | Aug 29, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 30, 2025 | $25.64M | Jul 28, 2025 |
| FY2025 | May 31, 2024 | $16.32M | Jul 28, 2025 |
| FY2024 | May 31, 2023 | $22.54M | Jul 30, 2024 |
| FY2023 | May 31, 2022 | $11.34M | Aug 28, 2023 |
| FY2022 | May 31, 2021 | $10.22M | Aug 26, 2022 |
| FY2021 | May 31, 2020 | $6.52M | Aug 27, 2021 |
| FY2020 | May 31, 2019 | $5.85M | Aug 28, 2020 |
| FY2019 | May 31, 2018 | $11.67M | Aug 28, 2019 |
| FY2018 | May 31, 2017 | $14.10M | Aug 28, 2018 |
| FY2017 | May 31, 2016 | $10.77M | Aug 29, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 30, 2025 | $122.87M | Jul 28, 2025 |
| FY2025 | May 31, 2024 | $111.59M | Jul 28, 2025 |
| FY2025 | May 31, 2023 | $75.60M | Jul 28, 2025 |
| FY2025 | May 31, 2022 | $50.99M | Jul 28, 2025 |
| FY2024 | May 31, 2021 | $11.45M | Jul 30, 2024 |
| FY2023 | May 31, 2020 | $14.06M | Aug 28, 2023 |
| FY2020 | May 31, 2019 | $15.47M | Aug 28, 2020 |
| FY2019 | May 31, 2018 | $19.31M | Aug 28, 2019 |
| FY2018 | May 31, 2017 | $16.81M | Aug 28, 2018 |
| FY2017 | May 31, 2016 | ($703.0K) | Aug 29, 2017 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 30, 2025 | $10.72M | Jul 28, 2025 |
| FY2025 | May 31, 2024 | $0 | Jul 28, 2025 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 30, 2025 | ($23.06M) | Jul 28, 2025 |
| FY2025 | May 31, 2024 | ($19.15M) | Jul 28, 2025 |
| FY2024 | May 31, 2023 | ($52.31M) | Jul 30, 2024 |
| FY2023 | May 31, 2022 | ($66.86M) | Aug 28, 2023 |
| FY2022 | May 31, 2021 | ($76.31M) | Aug 26, 2022 |
| FY2021 | May 31, 2020 | ($74.29M) | Aug 27, 2021 |
| FY2020 | May 31, 2019 | ($71.48M) | Aug 28, 2020 |
| FY2019 | May 31, 2018 | ($66.25M) | Aug 28, 2019 |
| FY2018 | May 31, 2017 | ($66.78M) | Aug 28, 2018 |
| FY2017 | May 31, 2016 | ($61.12M) | Aug 29, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 30, 2025 | $24.53M | Jul 28, 2025 |
| FY2025 | May 31, 2024 | $49.16M | Jul 28, 2025 |
| FY2024 | May 31, 2023 | $30.05M | Jul 30, 2024 |
| FY2023 | May 31, 2022 | $31.48M | Aug 28, 2023 |
| FY2022 | May 31, 2021 | $4.58M | Aug 26, 2022 |
| FY2021 | May 31, 2020 | $5.43M | Aug 27, 2021 |
| FY2021 | May 31, 2019 | $5.43M | Aug 27, 2021 |
| FY2020 | May 31, 2018 | $16.85M | Aug 28, 2020 |
| FY2019 | May 31, 2017 | $17.80M | Aug 28, 2019 |
| FY2019 | May 31, 2016 | $939.0K | Aug 28, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | May 31, 2018 | $0 | Aug 28, 2018 |
| FY2018 | May 31, 2017 | $6.11M | Aug 28, 2018 |
| FY2017 | May 31, 2016 | $5.96M | Aug 29, 2017 |
| FY2016 | May 31, 2015 | $3.79M | Aug 29, 2016 |
| FY2015 | May 31, 2014 | $0 | Aug 31, 2015 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 30, 2025 | 0 | Jul 28, 2025 |
| FY2025 | May 31, 2024 | 1 | Jul 28, 2025 |
| FY2025 | May 31, 2023 | 0 | Jul 28, 2025 |
| FY2022 | May 31, 2022 | 0 | Aug 26, 2022 |
| FY2022 | Feb 28, 2022 | 0 | Aug 26, 2022 |
| FY2022 | Nov 30, 2021 | 0 | Aug 26, 2022 |
| FY2022 | Aug 31, 2021 | 0 | Aug 26, 2022 |
| FY2022 | May 31, 2021 | 0 | Aug 26, 2022 |
| FY2022 | Feb 28, 2021 | 0 | Aug 26, 2022 |
| FY2022 | Nov 30, 2020 | 0 | Aug 26, 2022 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 30, 2025 | 0 | Jul 28, 2025 |
| FY2025 | May 31, 2024 | 1 | Jul 28, 2025 |
| FY2025 | May 31, 2023 | 0 | Jul 28, 2025 |
| FY2022 | May 31, 2022 | 0 | Aug 26, 2022 |
| FY2022 | Feb 28, 2022 | 0 | Aug 26, 2022 |
| FY2022 | Nov 30, 2021 | 0 | Aug 26, 2022 |
| FY2022 | Aug 31, 2021 | 0 | Aug 26, 2022 |
| FY2023 | May 31, 2021 | 0 | Aug 28, 2023 |
| FY2022 | May 31, 2020 | 0 | Aug 26, 2022 |
| FY2021 | May 31, 2019 | 0 | Aug 27, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 30, 2025 | 29.88M | Jul 28, 2025 |
| FY2025 | May 31, 2024 | 29.00M | Jul 28, 2025 |
| FY2024 | May 31, 2023 | 28.54M | Jul 30, 2024 |
| FY2023 | May 31, 2022 | 27.12M | Aug 28, 2023 |
| FY2022 | May 31, 2021 | 23,725 | Aug 26, 2022 |
| FY2021 | May 31, 2020 | 23,107 | Aug 27, 2021 |
| FY2020 | May 31, 2019 | 22,669 | Aug 28, 2020 |
| FY2019 | May 31, 2018 | 22,143 | Aug 28, 2019 |
| FY2018 | May 31, 2017 | 21.34M | Aug 28, 2018 |
| FY2017 | May 31, 2016 | 13.22M | Aug 29, 2017 |